Neisseria Meningitidis Infection  >>  Nimenrix (MenACWY-TT)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nimenrix (MenACWY-TT) / Pfizer
NCT00496015 / 2006-001481-17: Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A

Completed
3
750
RoW
Pneumococcal conjugate vaccine GSK1024850A., Infanrix hexa., DTPa-HBV-IPV/Hib, Meningococcal vaccine GSK134612., Mencevax™, Paracetamol.
GlaxoSmithKline
Infections, Streptococcal
03/08
02/09
NCT00508261 / 2006-006680-23: Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine

Completed
3
793
Europe
Meningococcal vaccine GSK134612, Infanrix™ hexa, Meningitec™
GlaxoSmithKline
Infections, Meningococcal
05/08
10/08
NCT00758264: Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration

Completed
3
363
RoW
Meningococcal vaccine GSK134612, Pneumococcal vaccine GSK1024850A
GlaxoSmithKline
Infections, Meningococcal
06/09
11/09
NCT00614614 / 2012-002401-22: Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014

Completed
3
1558
US
GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix), Nimenrix, GSK Biologicals' Hib-meningococcal vaccine GSK 792014 (Menhibrix), Menhibrix, Infanrix®, ActHIB®, Pediarix®
GlaxoSmithKline
Infections, Meningococcal
07/09
09/09
NCT01154088: Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds

Completed
3
1170
RoW
Mencevax ACWY, GSK Biologicals' meningococcal serogroup A, C, W-135, Y tetanus toxoid conjugate investigational vaccine [GSK 134612]
GlaxoSmithKline
Infections, Meningococcal
12/10
12/10
NCT01235975: Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years

Completed
3
400
RoW
Meningococcal vaccine GSK 134612, MencevaxACWY TM
GlaxoSmithKline
Infections, Meningococcal
07/11
08/11
NCT01641042 / 2011-002410-36: Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects

Completed
3
86
US, RoW
Meningococcal vaccine GSK134612
GlaxoSmithKline
Infections, Meningococcal
10/14
03/15

Download Options